Integra Speed Up
 

« Previous article
PharmaLab 2024 - Cal...

1st May 2024  Content supplied by: Ingenza Ltd

Ingenza Expands CodABLE® Gene Design Algorithm for Recombinant Protein Production


  • CRDMO Ingenza secured innovation funding to adapt its codABLE® machine learning platform for precise control of recombinant protein expression in Pichia pastoris.
  • Project aims to accelerate the development of therapeutics, enzymes, and other proteins by fine-tuning codon usage and maximizing production yields.
  • CodABLE® has already revolutionized protein expression in Bacillus subtilis, outperforming commercial DNA synthesis algorithms.
  • The company is deploying rapid, ultra-high throughput screening and next-generation sequencing to uncover the link between codon context and protein expression for valuable protein targets.


Scottish CRDMO Ingenza has secured innovation funding to adapt its codABLE® machine learning platform to precisely control recombinant protein expression in the industrial yeast Pichia pastoris. This game-changing project will accelerate the development of therapeutics, enzymes and other proteins by harnessing machine learning to fine-tune codon usage, ensuring seamless compatibility with the production host and maximising production yields.

Ingenza’s codABLE® platform has already revolutionised protein expression in Bacillus subtilis by maximising expression yields of challenging proteins for its customers, including endotoxin-free manufacture of biologics. codABLE® is achieving the ‘holy grail’ of accurately predicting protein expression from specific gene design, outperforming codon optimisation algorithms operated by commercial DNA synthesis providers. This offers a unique advantage in controlling protein expression without altering regulatory regions, such as promoters or ribosome binding sequences.

Ingenza will use this award from InnovateUK to establish its proven algorithm in P. pastoris, a powerhouse of protein biomanufacturing. To achieve this, the company is deploying rapid, ultra-high throughput screening and next generation sequencing (NGS) to dive deep into millions of gene variants, generating a dataset that will enable codABLE® to uncover the link between codon context and protein expression for valuable protein targets.

Rita Cruz, Head of Strain Development at Ingenza, commented: “Ingenza's codABLE® machine learning algorithm represents a step change in designing genes for predictable and optimised recombinant expression, a challenge that has hindered engineering biology until now. This approach combines cutting-edge computational technology with Ingenza’s broad expertise in over a dozen biomanufacturing hosts. It is undoubtedly increasing our business competitiveness and accelerating innovations in bio-based manufacturing."

Rita will be participating in an insightful panel discussion entitled Revolutionizing industrial biotech: harnessing the power of AI for enhanced efficiency, innovation, and sustainable solutions on the 8th of May 2024 at the SynBioBeta Global Synthetic Biology Conference in California.

Visit www.ingenza.com


Share on:

Tags:


Date Published: 1st May 2024

Source article link: View


View full company details